Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$98.51 USD

98.51
1,445,278

-0.29 (-0.29%)

Updated Jun 7, 2024 04:00 PM ET

After-Market: $98.50 -0.01 (-0.01%) 5:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (143 out of 248)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?

Is (CAH) Outperforming Other Medical Stocks This Year?

Sweta Killa headshot

Should Deep Value ETF (DVP) Be on Your Investing Radar?

Style Box ETF report for DVP

Here's Why You Should Hold on to Cardinal Health Stock Now

Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment. However, integration risks remain a concern.

Cardinal (CAH) Upgraded to Buy: Here's Why

Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here's Why You Should Retain Surmodics (SRDX) Stock for Now

Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.

Top Ranked Income Stocks to Buy for January 6th

Here are three stocks with buy rank and strong income characteristics for investors to consider today, January 6th.

Top Ranked Income Stocks to Buy for January 2nd

Here are three stocks with buy rank and strong income characteristics for investors to consider today, January 2nd.

Here's Why You Should Hold on to Intuitive Surgical for Now

Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction remains a concern.

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CAH or ALGN: Which Is the Better Value Stock Right Now?

CAH vs. ALGN: Which Stock Is the Better Value Option?

Should Deep Value ETF (DVP) Be on Your Investing Radar?

Style Box ETF report for DVP

Top Ranked Income Stocks to Buy for December 27th

Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 27th.

Top Ranked Income Stocks to Buy for December 20th

Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 20th.

Top Ranked Income Stocks to Buy for December 19th

Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 19th.

Here's Why You Should Invest in Cardinal Health Stock Now

Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment.

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Cardinal (CAH) Upgraded to Buy: Here's What You Should Know

Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cardinal (CAH) Up 3.1% Since Last Earnings Report: Can It Continue?

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Should Deep Value ETF (DVP) Be on Your Investing Radar?

Style Box ETF report for DVP

Here's Why You Should Hold on to HealthEquity (HQY) for Now

Buoyed by a solid fiscal third quarter, HealthEquity (HQY) raises its fiscal 2020 view.

Here's Why You Should Add Veeva (VEEV) to Your Portfolio Now

Buoyed by a solid fiscal third quarter, Veeva (VEEV) raises its fiscal 2020 revenue guidance.

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market. However, rising pricing pressure remains a concern.

Here's Why You Should Hold on to Surmodics (SRDX) Stock Now

Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.

Here's Why You Should Hold on to OPKO Health (OPK) Stock Now

OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.